Sandra Salm

Immunological aspects of cancer chemotherapy

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Influence of tumour micro-environment heterogeneity on therapeutic response

Volitional action as perceptual detection: Predictors of conscious intention in adolescents with tic disorders

The anticancer immune response: indispensable for therapeutic success?

Delivery technologies for cancer immunotherapy

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

Immunity, Inflammation, and Cancer

The immune contexture in human tumours: impact on clinical outcome

Sense of agency in the human brain

Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments

Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

NF-κB, inflammation, immunity and cancer: coming of age

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

Nanotechnology for Multimodal Synergistic Cancer Therapy

Advances in Cancer Immunotherapy in Solid Tumors

Immunogenic Cell Death in Cancer Therapy

Interleukin-2/interferon-α2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

The bereitschaftspotential in jerky movement disorders